Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.37 USD | +0.54% | +4.46% | -13.41% |
05-07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
05-01 | TD Cowen Adjusts Price Target on Incyte to $80 From $88 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.41% | 12.21B | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-15.40% | 31.87B | |
+53.49% | 24.52B | |
-14.35% | 15.68B | |
-39.65% | 12.23B | |
-6.52% | 12.34B | |
+6.22% | 8.83B | |
-6.43% | 8.28B |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation
- Oppenheimer Adjusts Incyte's Price Target to $98 From $109, Maintains Outperform Rating